谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

118O Definitive results for NSCLC and bladder cancer cohorts in the phase IIa trial of visugromab (CTL-002) in advanced/metastatic anti-PD/PD-L1 relapsed/refractory solid tumors (GDFATHER-trial)

I. Melero,M.J. De Miguel,G. Alonso Casal,G.A. De Velasco Oria,E. Ramelyte,M. Joerger,J. Martin-Liberal,D. König,C.M. Sayehli, T. Gromke,M.E. RodrÍguez-Ruiz, E. Calvo,E. Garralda, J.J. Soto-Castillo, R. Dummer, J. Esteban Villarrubia,M-E. Goebeler,P. Fettes,K. Klar,E. Leo

Immuno-Oncology and Technology（2023）

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要